InvestorsHub Logo
Followers 2
Posts 120
Boards Moderated 0
Alias Born 02/25/2012

Re: None

Tuesday, 08/12/2014 9:25:37 PM

Tuesday, August 12, 2014 9:25:37 PM

Post# of 232324
PRO140:potent, short-term, dose-dependent, highly significant antiviral activity

We aimed to assess the efficacy, safety, clinical disease progression and immunologic (CD4 count/percentage) and virologic (plasma HIV RNA viral load) markers of PRO 140 for HIV-infected patients in randomized controlled trials (RCTs) and quasi-randomized controlled trials (quasi-RCTs) .....


http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008439.pub3/abstract

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News